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OBJECTIVES: To examine whether low serum albumin is
associated with low muscle strength and future decline in
muscle strength in community-dwelling older men and
women.
DESIGN: Population-based cohort study.
SETTING: The Longitudinal Aging Study Amsterdam.
PARTICIPANTS: Six hundred seventy-six women and 644
men aged 65 to 88.
MEASUREMENTS: Serum albumin was determined at
baseline. Muscle strength was assessed using grip strength
at baseline, after 3 (n51,009), and 6 (n5741) years. The
outcomes were continuous baseline muscle strength,
3- and 6-year change in muscle strength, and a dichoto-
mous indicator for substantial decline (a decrease if 1
standard deviations for women511kg, for men5 12kg)
in muscle strength.
RESULTS: Mean serum albumin concentration 
standard deviation was 45.0  3.3 g/L for women and
45.2  3.2 g/L for men. At baseline, adjusting for age, life-
style factors, and chronic conditions, lower serum albumin
was cross-sectionally associated with weaker muscle
strength (Po.001) in women and men. After 3 years of
follow-up, mean decline in muscle strength was 5.6 
10.9 kg in women and  9.6  11.9 kg in men. After ad-
justment for potential confounders, lower serum albumin
was associated with muscle strength decline over 3 years
(Po.01) in women andmen (b50.57, standard error (SE)5
0.18; b50.37, SE50.16, respectively). Lower serum
albumin was also associated with substantial decline in
muscle strength in women (per unit albumin (g/L) adjusted
odds ratio (OR)5 1.14, one-sided 95% confidence limit
(CL)5 1.07) and men (per unit albumin (g/L) adjusted
OR51.14, 95% CL5 1.08). Similar but slightly weaker
associations were found between serum albumin and 6-year
change in muscle strength (Po.05).
CONCLUSION: These results suggest that low serum al-
bumin, even within the normal range, is independently as-
sociated with weaker muscle strength and future decline in
muscle strength in older women and men. J Am Geriatr Soc
53:1331–1338, 2005.
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The release of cytokines such as interleukin-6 (IL-6) andtumor necrosis factor (TNF), which induce the acute-
phase response, accompany inflammation.1 Proinflamma-
tory cytokines reduced serum albumin, a negative acute-
phase protein.1 It has also been suggested that proinflam-
matory cytokines reduce the synthesis of muscle proteins
and the stimulation of protein breakdown in experimental
studies in rats2–5 and in humans.6 This may cause sa-
rcopenia, characterized by a reduction in muscle strength
and muscle mass.7
Studies in which higher IL-6 and TNF-alpha levels were
associated with lower muscle mass and strength8 and de-
cline of muscle strength9 support this theory. Furthermore,
low muscle strength is associated with disability, poor mo-
bility, morbidity, and mortality.10–12 A reduction of muscle
strength and mass may ultimately lead to poorer physical
function,13 disability,14 and mortality.12
Low serum albumin concentration is a known marker
for poor health outcomes such as mortality, cardiovascular
disease, future functional limitations, and disability.15–18
One cross-sectional study has found an association between
lower serum albumin concentration and lower muscle
mass,19 but no (prospective) studies have yet examined the
relationship between serum albumin and muscle strength
and its change with age.
The objectives of the present study were to examine
whether low serum albumin is associated with low muscle
strength and whether low serum albumin is independently
associated with subsequent decline in muscle strength in a
population-based sample of older women and men. In ad-
dition, the role of inflammation as potential mediator of the
association was investigated.
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METHODS
Study Sample
The data presented were collected in the context of the
Longitudinal Aging Study Amsterdam (LASA), an ongoing
interdisciplinary cohort study that focuses on changes in
physical, cognitive, emotional, and social functioning in
older persons. The sampling and data collection have been
described in detail elsewhere.20 Briefly, a sample of older
women and men (aged 55–85), stratified by age, sex, ur-
banization, and expected 5-year mortality, was drawn from
the population registers of 11 municipalities in areas situ-
ated in the west (Amsterdam region), northeast (Zwolle
region), and south (Oss region) of the Netherlands.
The sample for this study comprised respondents who
participated in the first follow-up of LASA (1995/1996) and
were born in or before 1930 (aged 65 at January 1,
1996).21 In this study, the first follow-up of LASA will be
referred to as baseline measurement. During a medical in-
terview (n51,509), a nurse interviewer collected blood
samples from 1,328 respondents, for two of whom no se-
rum albumin levels were determined. Five respondents had
no data on muscle strength at baseline, and one respondent
was excluded because of extremely high muscle strength
levels (43 standard deviations above the mean), leaving a
study sample of 1,320 respondents. During follow-up,
muscle strength was measured in 1,009 respondents after 3
years and in 741 respondents after 6 years.
Of the 311 respondents with missing muscle strength
information after 3 years, 298 did not participate in the
follow-up examination (171 had died, 25 were ineligible
due to frailty, 51 refused, 46 had a telephone interview, and
5 could not be contacted), and 13 participated but had no
muscle strength measured. Of the 579 respondents with
missing muscle strength information after 6 years, 561 did
not participate in the follow-up examination (352 had died,
36 were ineligible due to frailty, 70 refused, 96 had a tel-
ephone interview, and 7 could not be contacted), and 18
participated but had no muscle strength measured.
Informed consent was obtained from all the respond-
ents. The medical ethics committee of the VU University
Medical Center in Amsterdam approved the study.
Serum Albumin
Nonfasting serum samples were obtained and analyzed di-
rectly. Serum samples obtained in Zwolle were analyzed in
the laboratory of the ISALA Clinic (Location Weezelan-
den), and serum samples obtained in Amsterdam and Oss
were analyzed in the laboratory of the VU University Med-
ical Center in Amsterdam.
Information from the Dutch Foundation for Quality
Assessment in Clinical Laboratories (SKZL) was used to
control for between-laboratory differences. Every 2
months, eight standard serum samples were sent to the
laboratories to be analyzed, and the serum albumin con-
centration was reported to the SKZL. Using linear regres-
sion, a regression line was fitted using the individual
laboratory assessment of serum albumin for each sample
and the overall national mean of the same sample. Separate
lines were fitted for each laboratory to adjust the serum
albumin levels in the LASA sample.
Serum albumin concentrations (g/L) were determined
using a bromcresol green photometric assay with a Hitachi
analyzer in the laboratory in Zwolle. The laboratory of the
VU University Medical Center used a bromcresol purple
method. To make the serum albumin levels comparable, the
serum albumin levels that were determined using the
bromcresol purple method were converted using a validat-
ed formula.22
Serum albumin was used as a continuous variable and
was categorized into sex-specific quartiles (women: first
quartile43 g/L, second quartile 43.1–44.6 g/L, third quar-
tile 44.7–47.1 g/L, and fourth quartile447.1 g/L (reference
group); in men: first quartile43 g/L, second quartile 43.1–
45 g/L, third quartile 45.1–47 g/L, and fourth quartile
447 g/L (reference group)) to examine potential nonline-
ar associations.
Muscle Strength
Muscle strength (kg) was assessed using grip strength and
measured using a strain-gauged dynamometer (Takei TKK
5001, Takei Scientific Instruments Co. Ltd, Tokyo, Japan).
Subjects stood with arms and wrists stretched out at the
sides of the body. They were asked to perform two max-
imum force trials with each hand. For the final scores, the
maximum values of the right and the left hand were
summed.23,24 When only one hand could be used in any
examination, the maximum value of that hand was doubled
for all examinations (n5 38).
Muscle strength at baseline and 3- and 6-year decline in
muscle strength were used as outcome variables. Change in
muscle strength was calculated as the follow-up muscle
strength minus baseline muscle strength. Change in muscle
strength was also used as a dichotomous variable by defin-
ing substantial decline in muscle strength as a decline of one
standard deviation (for 3-year decline in women 11kg and
in men 12 kg, for 6-year decline in women 10 kg and in men
13kg) or more.
Covariates
Baseline covariates included age, smoking status (never
(reference group), former, and current), alcohol consump-
tion (none (reference group), 1–2 drinks/d, 42 drinks/d),
body mass index (BMI; weight/height2), physical activity
(min/wk), serum total cholesterol (mMol/L), vitamin D and
parathyroid hormone (PTH) status, and chronic conditions.
The covariates were selected as potential confounders be-
cause they were associated at Po.20 with serum albumin
andmuscle strength or change inmuscle strength or because
they had been used as a confounder in previous studies.19
Physical activity in the previous 2 weeks was based on the
following activities: walking outdoors, cycling, light and
heavy household activities, and a maximum of two sports
activities.25 Serum total cholesterol was measured using an
enzymatic colorimetry assay with a Hitachi 747 analyzer.
Serum concentration of PTH was measured using immuno-
radiometric assay, and vitamin D was assessed using serum
25-hydroxyvitamin D and was determined using a compet-
itive binding protein assay summed.24 Chronic conditions
were self-reported and included the presence of diabetes
mellitus, arthritis, stroke, cardiac disease, depressive symp-
toms, and cognitive status. For depressive symptoms, the
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Center for Epidemiologic Studies Depression scale was
used;26 a score of 16 or greater was used to indicate de-
pression.27 Cognitive status was measured using the Mini-
Mental State Examination; a score of 23 or less was used to
indicate cognitive impairment.28 Covariates were missing
for some respondents: physical activity, n5 49; BMI,
n510; alcohol consumption, n51; serum total cholester-
ol, n518; serum vitamin D, n510; serum PTH, n510;
diabetes mellitus, n51; arthritis, n51; depressive symp-
toms, n538; and cognitive impairment, n53.
Inflammatory Markers
Other confounding factors, such as markers of inflamma-
tion, may contribute to the association between serum al-
bumin levels and low muscle strength or future decline in
muscle strength. As markers of inflammation, serum IL-6
concentration (pg/mL) and serum C-reactive protein (CRP)
concentration (mg/mL) were used. IL-6 and CRP were de-
termined using sensitive regular immunoassays at Sanquin
Research in Amsterdam. CRP was categorized in tertiles
(first tertile o1.9mg/mL (reference), second tertile 1.9–
5.1 mg/mL, and third tertile 45.1mg/mL). Because of the
high detection limit of 5 pg/mL, IL-6 was categorized in
three categories, with levels above the 5 pg/mL in the high-
est category. Persons with lower levels were divided in two
groups, based on the median level of IL-6 in this group (first
group 1.7 pg/mL (reference), second group 1.8–5.0 pg/
mL, third group45.0 pg/mL). Intermediating factors were
missing for some respondents (IL-6, n545; CRP, n544).
Statistical Analyses
In view of sex-related muscle strength differences29 and
because preliminary analyses showed a sex interaction for
the cross-sectional associations (P5.04), all analyses were
performed stratified by sex. Data were analyzed using the
statistical package SPSS 10.1 (SPSS Inc., Chicago, IL). De-
scriptive statistics were used to describe the respondents in
the study sample. Differences between included and ex-
cluded respondents were tested using descriptive statistics,
and statistical significance was considered present at the
two-sided P-value of .05. When examining the associations
between serum albumin and (change in) muscle strength,
one-sided statistical tests were performed at Po.05. The
use of the one-sided test corresponds to the one-sided hy-
pothesis that the lower the serum albumin concentration,
the weaker the muscle strength or the greater the decline in
muscle strength.30
Linear regression models were used to examine the re-
lationship between serum albumin and (change in) muscle
strength. Results are presented as regression coefficients (b)
with standard errors (SEs) with P-values. The P-value of the
two-sided statistical test in the output from the statistical
package was divided by two to make it a one-sided P-value.
A regression coefficient of  0.2 can be interpreted as a
decline in muscle strength of 0.2 kg during follow-up per
unit (g/L) of lower baseline serum albumin concentration.
Analyses of covariance were performed to examine the as-
sociation between quartiles of albumin and (change in)
muscle strength. Logistic regression models were used to
examine the relationship between (quartiles of) serum al-
bumin and the dichotomous variable substantial decline in
muscle strength. Results are presented as odds ratios (ORs)
with one-sided 95% confidence limits (CLs). The one-sided
95% CL was recalculated by hand to make it one-sided
using a z score of 1.65 instead of the 1.96 that is used for
two-sided tests. The analyses were adjusted for age,
andFwhen change in muscle strength (or substantial de-
cline) was the dependent variableFfor baseline muscle
strength in the first model. The second model additionally
included lifestyle factors such as smoking, alcohol con-
sumption, BMI, and physical activity. In the third model,
diabetes mellitus, cardiac disease, stroke, arthritis, cogni-
tive impairment, depression, serum total cholesterol, serum
vitamin D, and serum PTH were additionally adjusted for.
In the final model, results were additionally adjusted for the
inflammatory markers IL-6 and CRP.
Because it is known that persons with hand arthritis
perform poorly on muscle strength measures, analyses were
repeated excluding persons with pain or recent surgery to
the hands or who were observed to have hand rheumatoid
arthritis by the medical interviewer at baseline (n5309).
RESULTS
Study Sample
Baseline characteristics of the study sample are shown in
Table 1. Those included in the baseline sample (n51,320)
more often drank two or more glasses of alcohol daily, were
less cognitively impaired and less depressed, and reported
less often the presence of stroke than those excluded from
the baseline sample (n5189).
Participants with muscle strength measured after 3
years (n51,009), at baseline, were significantly younger;
were more often female; had higher muscle strength; a
higher serum albumin concentration, and higher BMI; more
often drank 2 or more glasses of alcohol daily; were more
physically active; had more education; were less cognitively
impaired and less depressed; and reported less often the
presence of diabetes mellitus, cardiac disease, and stroke
than those without muscle strength information (n5311).
Participants with muscle strength measured after 6
years (n5741), at baseline, were significantly younger;
were more often female; had higher muscle strength and a
higher serum albumin concentration; were more physically
active; had more education; were more often former or
nonsmokers; more often drank 2 or more glasses of alcohol
daily; had higher total cholesterol; were less cognitively
impaired; and reported less often the presence of diabetes
mellitus, cardiac disease, and stroke than those with no
muscle strength assessment (n5 579).
Serum Albumin and Muscle Strength
Mean baseline serum albumin concentration was 45.0 
3.3 g/L for women and 45.2  3.2 g/L for men. Mean base-
line muscle strength was 41.9  9.9 kg for women and
70.8  16.5 kg for men (Table 1).
Lower serum albumin was associated with weaker
muscle strength in women and men (b50.41, SE50.10
and b5 0.65, SE50.17, respectively; Po.001), after ad-
justment for age (Table 2). After additional adjustment for
lifestyle factors, chronic conditions, serum total cholesterol,
serum PTH, and serum vitamin D, the results remained
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statistically significant and were only slightly attenuated
(women b50.31, SE5 0.11; men b50.62, SE50.17,
Po.01). When CRP and IL-6 were added to the model, the
beta for baseline muscle strength was reduced but still sig-
nificantly associated with serum albumin.
As shown in Figure 1, women and men in the lower
quartiles of serum albumin had lower mean muscle strength
after adjustment for age, lifestyle factors, and chronic con-
ditions (P for trend in women5 .009 and in men5 .003).
Men in the first, second, and third quartile had significantly
lower mean muscle strength than those in the highest
quartile of serum albumin. Women in the first and second
quartile of serum albumin had significantly weaker mean
muscle strength than those in the highest quartile. When the
inflammatory markers were added to the model, the first
and second quartiles were not significantly different from
the highest quartile of serum albumin in women. In men,
the first and second quartile of serum albumin had signif-
icantly lower mean muscle strength than the highest quar-
tile of serum albumin (P.05).
Serum Albumin and Change in Muscle Strength
After 3 years of follow-up (women, n5 532; men, n5477),
mean decline in muscle strength was 5.6  10.9 kg in
Table 1. Characteristics of Participants of the Longitudinal Aging Study Amsterdam
Characteristic
Women Men
(n5 676) (n5 644)
Age, mean  SD 75.4  6.6 75.6  6.6
Cigarette smoking, %
Never 60.1 10.1
Former 27.8 64.8
Current 12.1 25.2
Alcohol consumption, drinks/day, %
0 34.2 14.0
o2 34.1 28.4
2 31.7 57.6
Body mass index, kg/m2, mean  SD 27.6  4.8 26.1  3.4
Physical activity, min/wk, mean  SD 174.2  102.7 124.8  98.0
Diabetes mellitus, % 8.9 6.4
Cardiac disease, % 20.6 32.1
Stroke, % 6.4 8.9
Arthritis, % 58.1 33.7
Cognitive impairment, % 11.8 11.1
Depression, % 20.7 8.5
Serum total cholesterol concentration, mmol/L, mean  SD 6.2  1.7 5.7  1.1
Serum vitamin D, nmol/L, mean  SD 48.9  22.9 57.9  24.5
Parathyroid hormone, pmol/L, mean  SD 3.6  2.5 3.7  2.5
Interleukin-6, mean  SD 3.0  5.3 2.9  4.1
C-reactive protein, mean  SD 6.7  14.4 6.9  12.8
Serum albumin concentration, g/L, mean  SD 45.0  3.3 45.2  3.2
Muscle strength at baseline, kg, mean  SD 41.9  9.9 70.8  16.5
3-year change in muscle strength, kg, mean  SD  5.6  10.9  9.6  11.9
6-year change in muscle strength, kg, mean  SD  5.6  9.9  10.6  13.2
SD5 standard deviation.
Table 2. Cross-Sectional Association Between Baseline Serum Albumin (g/L) and Baseline Muscle (kg) Strength in Women
and Men
Subjects
First model Second modelw Third modelz Fourth model§
b (Standard Error) P-value
Women 0.41 (0.10) o.001 0.36 (0.10) o.001 0.31 (0.11) .002 0.20 (0.11) .04
Men 0.65 (0.17) o.001 0.63 (0.17) o.001 0.62 (0.17) o.001 0.53 (0.18) .002
Adjusted for age.
wAdditionally adjusted for smoking, alcohol consumption, body mass index, and physical activity.
zAdditionally adjusted for diabetes mellitus, cardiac disease, stroke, arthritis, cognitive impairment, depression, total serum cholesterol, serum parathyroid hormone,
and serum vitamin D.
§Additionally adjusted for interleukin-6 and C-reactive protein.
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women and  9.6  11.9 kg in men. Of the women, 20.1%
experienced a substantial decline in 3-year muscle strength
(13 kg) and, of the men, 34.6% experienced a substantial
decline in muscle strength.
After adjustment for age, baseline muscle strength,
lifestyle factors, and chronic conditions, lower serum albu-
min concentration was associated with greater decline in
muscle strength over 3 years; women declined 0.37 kg and
men 0.57 kg during follow-up per unit (g/L) of lower albu-
min (Po.01, Table 3). After adjustment for IL-6 and CRP,
the results remained significant andwere slightly attenuated
(women b50.30 and men b50.53; Po.05). Figure 2
shows the adjusted mean 3-year change in muscle strength
for each serum albumin quartile. After full adjustment, a
linear trend was observed between quartiles of serum al-
bumin and 3-year change in muscle strength in men (P for
trend5 .002). In women, those in the second serum albu-
min quartile differed significantly in muscle strength decline
from those in the highest quartile. After adjustment for
markers of inflammation, the results did not change. During
follow-up, men showed a greater decline in muscle strength
than women, but when the analyses were repeated, replac-
ing absolute change (kg) in muscle strength with relative
change (%) in muscle strength, the decline in muscle
strength was similar for men and women (data not shown).
Regarding substantial muscle strength decline, lower
serum albumin concentration was associated with substan-
tial 3-year decline in muscle strength in women (per unit
(g/L) albuminOR51.14, 95%CL51.07) andmen (per unit
(g/L) albumin OR5 1.14, 95% CL51.08) (Table 4). After
adjustment for potential confounders and markers of in-
flammation, these results did not change markedly. As
shown in Figure 3, women and men in the lowest three
quartiles of serum albumin showed a greater risk of sub-
stantial decline in muscle strength than those in the highest
quartile after adjusting for age, baseline muscle strength,
lifestyle factors, and chronic conditions. These results did
not markedly change after additional adjusting for IL-6 and
CRP.
With regard to measured muscle strength at 6 years
of follow-up (women, n5400; men, n5341), the mean
Table 3. Longitudinal Association Between Baseline Serum Albumin (g/L) and Subsequent 3-Year Decline in Muscle
Strength (kg) in Women and Men
Subjects
First model Second modelw Third modelz Fourth model§
b (Standard Error) P-value
Women 0.42 (0.15) .002 0.42 (0.15) .003 0.37 (0.16) .009 0.30 (0.17) .04
Men 0.61 (0.17) o.001 0.63 (0.17) o.001 0.57 (0.18) .001 0.53 (0.19) .003
Adjusted for baseline muscle strength and age.
wAdditionally adjusted for smoking, alcohol consumption, body mass index, and physical activity.
zAdditionally adjusted for diabetes mellitus, cardiac disease, stroke, arthritis, cognitive impairment, depression, total serum cholesterol, serum parathyroid hormone,
and serum vitamin D.
§Additionally adjusted for interleukin-6 and C-reactive protein.
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Figure 1. Mean muscle strength at baseline according to
sex-specific quartiles of serum albumin concentration (g/L)
after adjustment for age, lifestyle factors, and chronic conditions
(including serum total cholesterol, parathyroid hormone, and
vitamin D). Serum albumin quartiles in women: 1.43.0 g/L; 2.
43.1–44.6 g/L; 3. 44.7–47.1 g/L; 4.447.1 g/L. Serum albumin
quartiles in men 1. 43.0 g/L; 2. 43.1–45.0 g/L; 3. 45.1–47.0 g/
L; 4. 447.0 g/L. Po.10, w.05, z.001; P-values indicate statis-
tically significant differences in mean muscle strength when
compared with the highest quartile of serum albumin.
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Figure 2. Mean change in muscle strength over 3 years accord-
ing to sex-specific quartiles of serum albumin concentration
(g/L) after adjustment for baseline muscle strength, age, lifestyle
factors, and chronic conditions (including serum total choles-
terol, parathyroid hormone, and vitamin D). Serum albumin
quartiles in women: 1.43.0 g/L; 2. 43.1–44.6 g/L; 3. 44.7–47.1
g/L; 4.447.1 g/L. Serum albumin quartiles in men 1.43.0 g/L;
2. 43.1–45.0 g/L; 3. 45.1–47.0 g/L; 4.447.0 g/L. Po.10, w.05,
z.001; P-values indicate statistically significant differences in
mean muscle strength when compared with the highest quartile
of serum albumin.
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decline in muscle strength was  5.6  9.9 kg in women
and  10.6  13.2 kg inmen. In total, 20.3%of the women
and 39.0% of the men experienced a substantial decline in
muscle strength. The association between serum albu-
minFused continuously as well as in quartilesFand 6-year
change in muscle strength was similar but slightly weaker
than the association with 3-year change in muscle strength
(for continuous: women b50.28, SE5 0.16 kg; men
b5 0.39, SE50.23; for quartiles: 1st to 4th quartiles for
women:  6.50,  5.95, 6.34, 4.25, P for trend5 .16;
for men:  13.20, 10.04,  11.48, 8.45, P for
trend5 .07). With respect to 6-year substantial muscle
strength decline, similar results were observed as for 3-year
substantial decline (per unit (g/L) lower serum albumin
(women, OR51.08, 95% CL51.01; men, OR51.09,
95% CL51.01; first quartile vs highest quartile: women,
OR51.97, 95% CL51. 10; men, OR52.42, 95%
CL51.26).
Restricting the analyses to older persons without pain
or recent surgery to the hands and without the medical in-
terviewer having observed rheumatoid arthritis showed
similar results (data not shown).
DISCUSSION
The present study shows that low serum albumin, even
within the normal range, is associated with weaker muscle
strength, even after adjustment for age, lifestyle factors,
chronic conditions, serum total cholesterol, PTH, and vi-
tamin D. After additional adjustment for inflammatory
markers, the association between low serum albumin and
weaker muscle strength was somewhat less, indicating that
inflammation could only partly explain the associations. To
the authors’ knowledge, this is the first study examining the
cross-sectional association between serum albumin and
muscle strength. Muscle strength was assessed using grip
strength, which is a well-accepted indicator of overall mus-
cle strength.23,31 Furthermore, muscle strength is associated
with disability, poor mobility, and mortality.10–12 Previous-
ly, an association between low serum albumin and low
muscle mass was observed.19 Together with the present
findings, these results suggest that low serum albumin with-
in the normal range may be independently associated with
sarcopenia.
Moreover, this study extends the previous findings by
showing that low serum albumin concentration within the
normal range is associated with subsequent decline in mus-
cle strength after adjustment. When inflammation markers
were included in the final model, the association between
low albumin and subsequent decline in muscle strength was
reduced. These results are even more remarkable when
considering that 99% of the study sample had normal se-
rum albumin levels (438 g/L). Muscle strength decline is an
independent predictor of poorer physical function13 and
mortality.12
Identifying early determinants of loss of muscle
strength might be important in older persons to prevent
the deterioration of health and physical functioning. The
associations found in this study were obtained from an ob-
servational cohort study. Intervention studies using nutri-
tional supplements in older hemodialysis patients, critically
ill older inpatients, frail older persons, and persons in el-
derly homes have found conflicting results. This information
has only been conducted in older frail populations. There-
fore, future intervention studies, for example, nutritional
Table 4. Longitudinal Association Between Baseline Serum Albumin (g/L) and Subsequent 3-Year Substantial Decline in
Muscle Strength (kg) in Women and Men
Subjects
First modelw Second modelz Third model§ Fourth modelk
Odds Ratio (95% Confidence Limit) P-value
Women 1.14 (1.07) o.001 1.14 (1.07) o.001 1.13 (1.06) .001 1.11 (1.03) .008
Men 1.14 (1.08) o.001 1.14 (1.08) o.001 1.13 (1.07) o.001 1.13 (1.06) o.001
Decline of one standard deviation (women 11 kg, men 12 kg) or more during 3 years of follow-up.
wAdjusted for baseline muscle strength and age.
zAdditionally adjusted for smoking, alcohol consumption, body mass index, and physical activity.
§Additionally adjusted for diabetes mellitus, cardiac disease, stroke, arthritis, cognitive impairment, depression, total serum cholesterol, serum parathyroid hormone,
and serum vitamin D.
kAdditionally adjusted for interleukin-6 and C-reactive protein.
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Figure 3. Risk of substantial decline in muscle strength over 3
years according to sex-specific quartiles of serum albumin con-
centration (g/L) after adjustment for baseline muscle strength,
age, lifestyle factors and chronic conditions (including serum
total cholesterol, parathyroid hormone, and vitamin D). Serum
albumin quartiles in women: 1. 43.0 g/L; 2. 43.1–44.6 g/L; 3.
44.7–47.1 g/L; 4.447.1 g/L. Serum albumin quartiles in men 1.
43.0 g/L; 2. 43.1–45.0 g/L; 3. 45.1–47.0 g/L; 4. 447.0 g/L.
The highest quartile of serum albumin (447.0 g/L) is the ref-
erence group. 95% CL5 one-sided 95% confidence limit.
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intervention studies, should determine whether increasing
serum albumin concentrations will improve or stabilize
muscle strength in older persons. It is well established that
exercise can increase muscle strength in older persons.32,33
Combining different interventions might be most favorable
in preventing sarcopenia and its negative consequences for
physical functioning in older persons.
Potential mechanisms might explain the observed as-
sociation between serum albumin and muscle strength. The
first mechanism, already referred to in the introduction,
is the role of low-grade inflammation. Briefly, several
cytokines downregulate serum albumin concentration (neg-
ative acute-phase response) and increase muscle protein
breakdown.1,6 In experimental studies, administration of
IL-6 reduces the total skeletal muscle amino acid concen-
tration and causes muscle wasting.2–5 These effects of the
inflammatory cytokines induces a catabolic state that may
lead to a reduction in muscle strength and muscle mass, but
the inflammation markers could only partly explain the as-
sociations between serum albumin and weaker muscle
strength and future decline in muscle strength, suggesting
that other mechanisms are active as well. A second mech-
anism might be nutritional status. Nutritional problems
might be expected when older persons are living alone, have
functional or cognitive impairments, use multiple medica-
tions or alcohol, or have limited income. The recommended
nutrient intake is still based on younger populations, and
this intake might not be sufficient for older persons. Low
serum albumin is associated with low nutritional status.
With malnutrition, degradation of protein synthesis is the
main source of amino acids for protein synthesis. This may
lead to muscle strength decline.1,34–36
Because this is the first study to examine the association
between serum albumin and sarcopenia, further research is
suggested on this topic. Future research should confirm the
role of albumin in the development of sarcopenia. It may
also be worthwhile to further explore the underlying mech-
anisms of the association between serum albumin and
weaker muscle strength and future decline of muscle
strength.
Some limitations of this study should be addressed.
First, these results cannot be generalized to frail or institu-
tionalized persons because this study was conducted
in a relatively healthy, population-based study sample
aged 65 and older. Second, participants excluded from
the statistical analyses had lower serum albumin levels,
weaker muscle strength, and poorer health status than
those included. This might have resulted in an under- or
overestimation of the relationship between serum albumin
concentration and (change in) muscle strength.
Serum albumin and muscle strength are related to nu-
tritional status. Because no data on dietary intake were
available, BMI was used as an indirect marker for caloric
intake and not as marker for nutrient intake. Nevertheless,
serum albumin remained significantly associated with
(change in) muscle strength after adjustment for BMI.
In conclusion, low serum albumin concentration, even
within the normal range, was associated with lower muscle
strength in older women and men. Moreover, low serum
albumin was independently associated with 3- and 6-year
loss of muscle strength. Serum albumin may be used as an
early marker for future decline in muscle strength.
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